Call Now LINE WhatsApp
Chat on WeChat
WeChat QR Scan to connect with your dedicated consultant
⚠️ Mpox Outbreak Resurgence: The Scientific Truths We Need to Know
新闻 | 2026年6月28日

⚠️ Mpox Outbreak Resurgence: The Scientific Truths We Need to Know

 

✨ ⚠️ Mpox Outbreak Resurgence: The Scientific Truths We Need to Know

With the World Health Organization (WHO) once again declaring Mpox a “Public Health Emergency of International Concern” (PHEIC) in August 2024, this virus has returned to the public spotlight. Understanding its evolutionary characteristics and scientific prevention knowledge is crucial for reducing the risk of infection.

🩺 Quick Summary

📌 What is New About This Outbreak?

The core change in this outbreak is the emergence of the Clade Ib strain. Compared to the previously prevalent Clade IIb, Clade Ib has demonstrated higher transmission efficiency and pathogenic potential in the Democratic Republic of the Congo and surrounding countries [Source: WHO].

Prevention and control strategies have adjusted accordingly: while Mpox was previously thought to spread primarily among specific high-risk groups, current monitoring data indicates that the virus has spread through household contact and caregiving. The proportion of children among the infected population has increased. This means the focus of prevention has shifted from targeting specific populations to monitoring and prevention across the entire society [Source: WHO].

 

🧬 What Does This Mean for the General Public?

🔹 1. Identifying Typical Symptoms

The course of Mpox is typically divided into two stages:
* Prodromal Phase: Characterized by fever, severe headache, lymphadenopathy (swollen lymph nodes), muscle aches, and fatigue.
* Eruptive Phase: The rash usually progresses through the stages of maculopapular $\rightarrow$ vesicle $\rightarrow$ pustule $\rightarrow$ crust $\rightarrow$ desquamation (peeling).
* Special Note: Clinical manifestations of the Clade Ib strain may be more severe, with a wider distribution of rashes and faster disease progression [Source: Research Report].

🔹 2. Transmission Routes and Risk Management

Mpox is primarily transmitted through the following ways:
* Direct Contact: Contact with an infected person’s body fluids, rashes, or contaminated items (such as bed linens and clothing).
* Vertical Transmission: Pregnant women may transmit the virus to the fetus.
* Medical Protection: In healthcare facilities, medical staff must take strict protective measures (such as wearing N95 masks and protective clothing). Those isolating at home must remain in isolation until all rashes have completely scabbed over and fallen off [Source: Research Report].

🔹 3. Vaccines and Prevention

The third-generation modified vaccinia vaccine (MVA-BN, such as Jynneos/Imvanex) is currently recommended. Vaccination strategies include prophylactic vaccination and post-exposure prophylaxis (PEP), the latter of which is recommended within 4 days after contact for optimal protection. If suspected symptoms appear, a PCR nucleic acid test should be performed immediately for confirmation [Source: Research Report].

💊 Points of Caution

There are still some scientific “knowledge gaps” regarding Mpox that require further research to clarify:
* Long-term Effects: There is currently a lack of systematic data on long-term sequelae (such as scarring or vision impairment) following Clade Ib infection.
* Vaccine Efficacy: More clinical evidence is needed to support the precise protection rate of vaccines designed for Clade II against Clade Ib.
* Treatment Protocols: The optimal clinical treatment regimen using antiviral drugs (such as Tecovirimat) for Clade Ib is still being explored.
* Asymptomatic Transmission: It is currently unclear whether Clade Ib has a significant asymptomatic transmission period [Source: Research Report].

🔬 Clarifying Common Misconceptions

✨ Sources Used for This Article

© 慧子国際医療支援株式会社 All rights reserved | Unauthorized reproduction is prohibited.

Free Consultation Available
Free Online Consultation